GU Cancers 2019 | A promising treatment for prostate cancer

What’s really also very interesting is if you looked at those three presentations yesterday showing that patients either with non-metastatic CRPC or with castration-sensitive disease that is metastatic, improving overall survival. There are multiple trials now that are ongoing in the rising PSA circumstance and also in a localized disease circumstance, in which those

What’s really also very interesting is if you looked at those three presentations yesterday showing that patients either with non-metastatic CRPC or with castration-sensitive disease that is metastatic, improving overall survival. There are multiple trials now that are ongoing in the rising PSA circumstance and also in a localized disease circumstance, in which those therapies are also being brought even earlier in the disease. And so there you really get into the very earliest phases of the disease where you have the potential, of course, if you can hit the right combination of active systemic therapies and local interventions potentially to significantly improve overall survival in patients, if not, get rid of their disease in patients for whom they would be otherwise at high risk of relapse and dying of disease.

GU Cancers 2019 | A promising treatment for prostate cancer

Transcript

Related Videos

GU Cancers 2019 | A promising treatment for prostate cancer

Transcript

More from Michael Morris

Related Videos

Cookie settings